NYSE - Delayed Quote • USD
Stevanato Group S.p.A. (STVN)
At close: May 17 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 10 | 10 |
| Avg. Estimate | 0.11 | 0.15 | 0.57 | 0.69 |
| Low Estimate | 0.1 | 0.13 | 0.53 | 0.61 |
| High Estimate | 0.12 | 0.16 | 0.66 | 0.79 |
| Year Ago EPS | 0.15 | 0.16 | 0.63 | 0.57 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 10 | 10 |
| Avg. Estimate | 279.76M | 316.35M | 1.24B | 1.37B |
| Low Estimate | 274.41M | 303.58M | 1.22B | 1.32B |
| High Estimate | 290.09M | 323.62M | 1.29B | 1.48B |
| Year Ago Sales | 266.75M | 296.18M | 1.18B | 1.24B |
| Sales Growth (year/est) | 4.90% | 6.80% | 4.50% | 11.20% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.14 | 0.17 | 0.21 | 0.12 |
| EPS Actual | 0.15 | 0.16 | 0.2 | 0.09 |
| Difference | 0.01 | -0.01 | -0.01 | -0.03 |
| Surprise % | 7.10% | -5.90% | -4.80% | -25.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.11 | 0.15 | 0.57 | 0.69 |
| 7 Days Ago | 0.15 | 0.18 | 0.67 | 0.78 |
| 30 Days Ago | 0.15 | 0.18 | 0.66 | 0.77 |
| 60 Days Ago | 0.15 | 0.18 | 0.68 | 0.79 |
| 90 Days Ago | 0.16 | 0.19 | 0.72 | 0.84 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 9 | 9 | 9 | 9 |
Growth Estimates
| CURRENCY IN USD | STVN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -26.70% | -- | -- | 8.00% |
| Next Qtr. | -6.30% | -- | -- | 12.40% |
| Current Year | -9.50% | -- | -- | 5.60% |
| Next Year | 21.10% | -- | -- | 13.00% |
| Next 5 Years (per annum) | 4.18% | -- | -- | 11.14% |
| Past 5 Years (per annum) | 4.33% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/22/2024 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 3/25/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 11/1/2023 |
| Downgrade | Jefferies: Buy to Hold | 11/1/2023 |
| Initiated | Stephens & Co.: Overweight | 9/26/2023 |
| Initiated | CJS Securities: Market Outperform | 9/19/2023 |
Related Tickers
WST West Pharmaceutical Services, Inc.
355.64
+0.43%
1SXP.DE SCHOTT Pharma AG & Co. KGaA
31.52
-1.50%
GXI.DE Gerresheimer AG
99.40
-2.64%
NVST Envista Holdings Corporation
18.53
-3.14%
DIM.PA Sartorius Stedim Biotech S.A.
196.80
-4.33%
ICUI ICU Medical, Inc.
103.99
-2.15%
AKYA Akoya Biosciences, Inc.
2.8500
-1.72%
ALC Alcon Inc.
88.83
-0.26%
XRAY DENTSPLY SIRONA Inc.
28.28
-0.35%
RGEN Repligen Corporation
171.94
+0.53%